How does Lecanemab work, and what are its side effects?

Question

Hello doctor,

I am a 34-year-old male, and my mother is 56. Recently, I came across a new drug called Lecanemab for Alzheimer's disease. My mother was diagnosed with early-stage Alzheimer's last year, and I am curious if this could be a treatment option for her. Could you explain how Lecanemab works and its effectiveness in slowing dementia progression? Are there any notable side effects we should be aware of? Additionally, at which stage of Alzheimer's is this drug most beneficial? Can you please assist me?

Thank you.

Answer 1

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

Lecanemab shows promising potential as an investigational drug for Alzheimer's disease (a progressive neurological disorder that primarily affects memory and cognitive functions), with its mechanism and potential benefits being crucial to understanding. Here is an overview based on current research:

Mechanism of action: Lecanemab targets amyloid beta plaques in the brain, which are implicated in the development and progression of Alzheimer's disease. As an antibody, it binds to and aids in clearing these plaques, potentially mitigating their detrimental impact on brain function.
Effectiveness and clinical trials: Clinical trials have yielded mixed results regarding Lecanemab's effectiveness in slowing the progression of Alzheimer's disease. While some studies suggest it may reduce cognitive decline, others have not shown significant effects.
Comparison with Aducanumab: Similar to Aducanumab, another antibody targeting amyloid beta, Lecanemab has shown similarities in its approach. Aducanumab recently received FDA (Food and Drug Administration) approval under strict conditions due to the modest benefits observed in reducing cognitive decline.
Side effects: Common side effects noted in Lecanemab trials include headache, infusion-related reactions (like flushing or fever), and a potential increase in amyloid-related imaging abnormalities (ARIA), which can manifest as changes on brain scans and sometimes lead to symptoms such as headaches or confusion.
Stage of Alzheimer's disease: Lecanemab and similar drugs are typically studied in individuals with early-stage Alzheimer's disease, where amyloid beta plaques are more prevalent. Early intervention aims to slow cognitive decline before potentially irreversible damage occurs.

I suggest the following considerations for treatment:

Consultation with a neurologist: It is crucial to discuss Lecanemab with your mother's neurologist or healthcare provider, who is familiar with her case, to determine if she's a suitable candidate based on her health status and disease progression.
Clinical trial participation: If Lecanemab isn't yet approved or accessible outside clinical trials, research studies could provide access to the medication under controlled conditions and contribute to advancing Alzheimer's treatment.
Exploring other options: In addition to Lecanemab, other medications, therapies, and lifestyle adjustments may help manage symptoms and enhance quality of life. Your mother's healthcare team can provide tailored guidance on these options.

Navigating Alzheimer's treatment choices involves staying well-informed and collaborating closely with healthcare professionals who can offer up-to-date information on Lecanemab's potential benefits, risks, and suitability for your mother's care plan.

I hope this helps.

Please revert to assist you further.

Thank you.